Form D · Biotechnology

ATHEROTECH, INC.

Birmingham, AL · CIK 0001123915

Offering snapshot reported Oct 19, 2009 · SEC filing

Reported sold
$999K
Offering amount: $999K
Investors reported
24
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 13, 2009
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 19, 2009Initial$999,131No comparison24SEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-39547

Source: Form D, filed Oct 19, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

CAFFEINATED CAPITAL LOFT SPV, LLC

Investment adviser: CAFFEINATED CAPITAL MANAGEMENT, LLC

Gross asset value
$8.35M
Beneficial owners
24
ADV minimum commitment
$0

Reported in Form ADV on Mar 30, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator ADURO ADVISORS, LLC DENVER, Colorado, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor FRANK, RIMERMAN & CO. LLP PALO ALTO, California, United States
Custodian JPMORGAN CHASE BANK, NATIONAL ASSOCIATION COLUMBUS, Ohio, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

FRANK, RIMERMAN & CO. LLP
PCAOB 1596

JPMORGAN CHASE BANK, NATIONAL ASSOCIATION
LEI 7H6GLXDRUGQFU57RNE97

Filing source

Form ADV 2069786 · Mar 30, 2026 · Schedule D 7.B.(1), fund 805-8810328681

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Lawrence W. Greer Director
Alain Harrus Director
Laura King Director
Michael V. Mullen Executive
Robert Shufflebarger Executive
Kneeland Youngblood Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
201 London Parkway
Birmingham, AL, 35211